Clinical Trial Detail

NCT ID NCT01729091
Title Study of Umbilical Cord Blood-derived Natural Killer Cells in Conjunction With High Dose Chemotherapy and Autologous Stem Cell Transplant for Patients With Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

multiple myeloma

Therapies

Dexamethasone

Elotuzumab

Filgrastim

Melphalan

Lenalidomide

Age Groups: senior adult

No variant requirements are available.